Clinical Trial Update: Effects of Sitagliptin in Relatives of T1D Patients [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial evaluating sitagliptin in relatives of patients with type 1 diabetes, currently not yet recruiting (Phase 2/Phase 3).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Sitagliptin (sitagliptin)

Snippet

Sponsor: University of Milan | Conditions: Type 1 Diabetes | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING